Allojoin

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis
CP Wire
Fri, 03/16/18 - 11:17 am
Cellular Biomedicine
Allojoin
stem cells
osteoarthritis of the knee